Comparison of the CAMI-NSTEMI and GRACE Risk Model for Predicting In-Hospital Mortality in Chinese Non-ST-Segment Elevation Myocardial Infarction Patients
Cardiology Research and Practice · 24.07.2020 · 2020 · 1-6
DOI: 10.1155/2020/2469281 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cardiology Research and Practice, erschienen am 24.07.2020. Verfasst von Peng Wang und 3 weiteren Autor:innen. Beteiligte Einrichtung: Tianjin Medical University, Tianjin, China. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 21 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Key Project of Scientific and Technological Support Plan of Tianjin.
Abstract (Originalsprache)
Introduction
The ability of risk models to predict in-hospital mortality and the influence on downstream therapeutic strategy has not been fully investigated in Chinese Non-ST-segment elevation myocardial infarction (NSTEMI) patients. Thus, we sought to validate and compare the performance of the Global Registry of Acute Coronary Events risk model (GRM) and China Acute Myocardial Infarction risk model (CRM) and investigate impacts of the two models on the selection of downstream therapeutic strategies among these patients.
Methods
We identified 2587 consecutive patients with NSTEMI. The primary endpoint was in-hospital death. For each patient, the predicted mortality was calculated according to GRM and CRM, respectively. The area under the receiver operating characteristic curve (AUC), Hosmer–Lemeshow (H–L) test, and net reclassification improvement (NRI) were used to assess the performance of models.
Results
In-hospital death occurred in 4.89% (126/2587) patients. Compared to GRM, CRM demonstrated a larger AUC (0.809 versus 0.752, p < 0 . 0001 ), less discrepancy between observed and predicted mortality (H–L χ 2 : 22.71 for GRM, p = 0 . 0038 and 10.25 for CRM, p = 0 . 2479 ), and positive NRI (0.3311, p < 0 . 0001 ), resulting in a significant change of downstream therapeutic strategy.
Conclusion
In Chinese NSTEMI patients, the CRM provided a more accurate estimation for in-hospital mortality, and application of the CRM instead of the GRM changes the downstream therapeutic strategy remarkably.
Autor:innen und Institutionen
- Tianjin Medical University, Tianjin, China.
- Department of Cardiology, Tianjin Chest Hospital, Tianjin, China.
ORCID-Profile: Hongliang Cong
Förderung
- Key Project of Scientific and Technological Support Plan of Tianjin
Zitieren
APA
Wang, P., Cong, H., Zhang, Y., & Liu, Y. (2020). Comparison of the CAMI-NSTEMI and GRACE Risk Model for Predicting In-Hospital Mortality in Chinese Non-ST-Segment Elevation Myocardial Infarction Patients. Cardiology Research and Practice, 2020, 1-6. https://doi.org/10.1155/2020/2469281
Vancouver
Wang P, Cong H, Zhang Y, Liu Y. Comparison of the CAMI-NSTEMI and GRACE Risk Model for Predicting In-Hospital Mortality in Chinese Non-ST-Segment Elevation Myocardial Infarction Patients. Cardiology Research and Practice. 2020;2020:1-6. doi:10.1155/2020/2469281
BibTeX
@article{Wang2020,
author = {Wang, Peng and Cong, Hongliang and Zhang, Ying and Liu, Yujie},
title = {Comparison of the CAMI-NSTEMI and GRACE Risk Model for Predicting In-Hospital Mortality in Chinese Non-ST-Segment Elevation Myocardial Infarction Patients},
journal = {Cardiology Research and Practice},
year = {2020},
volume = {2020},
pages = {1--6},
doi = {10.1155/2020/2469281}
}
EUVIMED